Top compounds associated with response to LINC01125


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.084 0.07
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.08
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.059 0.08
mRNA lapatinib CCLE pan-cancer AAC -0.079 0.08
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.065 0.08
mRNA BRD-K41597374 CTRPv2 pan-cancer AAC 0.062 0.08
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.08
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.08
mRNA YK 4-279 CTRPv2 pan-cancer AAC 0.056 0.08
mRNA AZD6244 CCLE pan-cancer AAC -0.077 0.08
Download CSV